Found this on the internet, but i know nothing about the drug. I dont know what you are taking it for so here is the whole list of what the dosages are for each different symptom-
DOSAGE AND DIRECTIONS FOR USE
Dosage must be individualised.
See WARNINGS regarding hypotension in salt and volume depleted patients.
APO-CAPTOPRIL should be taken one hour before food intake.
Hypertension: The initial dose of APO-CAPTOPRIL is 25 mg two or three times a day. If a satisfactory reduction of blood pressure has not been achieved after two weeks the dose of APO-CAPTOPRIL may be increased to 50 mg two to three times a day. If after an additional two weeks a further reduction in blood pressure is desirable, a diuretic may be added. For patients already receiving a diuretic, the initial dose of APO-CAPTOPRIL should be lower and administered with care.
The dose of APO-CAPTOPRIL in mild to moderate hypertension must not exceed 150 mg per day.
When APO-CAPTOPRIL is used alone, concomitant sodium restriction may be beneficial.
APO-CAPTOPRIL may be used advantageously in conjunction with other anti-hypertensive agents.
Congestive Heart Failure: APO-CAPTOPRIL therapy must be started under close medical supervision. It should be added to conventional treatment with diuretic (and digitalis where indicated). A starting dose of 6,25 mg to 12,5 mg three times a day minimises the duration of any transient hypotensive effect. (See WARNINGS). This dosage may be increased over a period of one to two weeks to 75 - 300 mg per day.
Left Ventricular Dysfunction After Myocardial Infarction: Therapy may be initiated as early as three days following a myocardial infarction. After an initial dose of 6,25 mg APO-CAPTOPRIL therapy should be increased to 12,5 mg three times a day as tolerated. APO-CAPTOPRIL should then be increased as tolerated to 75 mg a day divided doses during the next several days and to a final target dose of 150 mg daily in divided doses over the next several weeks.
If symptomatic hypotension occurs, a dosage reduction may be required. Subsequent attempts at achieving the target dose of 150 mg should be based on the patient's tolerance to APO-CAPTOPRIL.
APO-CAPTOPRIL may be used in patients with other postmyocardial infarction therapies, e.g. thrombolytics, aspirin and beta blockers.
Patients with renal impairment: APO-CAPTOPRIL excretion is reduced in the presence of impaired renal function. After the desired therapeutic effect has been achieved the total daily dose should be reduced or the dose intervals increased.
The following maximum daily doses are suggested as a guide to minimise drug accumulation.
Please Scroll Down to See Forums Below 
